PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?

The high recurrence rate and the low overall survival in ovarian cancer suggest that a more specific therapeutic approach in addition to conventional treatment is required. Translational and clinical research is investigating new molecular targets in order to find an alternative way to affect tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasparri, Maria Luisa, Bardhi, Erlisa, Ruscito, Ilary, Papadia, Andrea, Farooqi, Ammad Ahmad, Marchetti, Claudia, Bogani, Giorgio, Ceccacci, Irene, Mueller, Michael D., Benedetti Panici, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658232/
https://www.ncbi.nlm.nih.gov/pubmed/29093603
http://dx.doi.org/10.1055/s-0043-118907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658232/
https://www.ncbi.nlm.nih.gov/pubmed/29093603
http://dx.doi.org/10.1055/s-0043-118907

Ejemplares similares